Literature DB >> 2437322

Cross-reactive neutralization epitopes on VP3 of human rotavirus: analysis with monoclonal antibodies and antigenic variants.

K Taniguchi, Y Morita, T Urasawa, S Urasawa.   

Abstract

We analyzed cross-reactive neutralization epitopes on protein VP3 of human rotavirus (HRV) by the use of neutralizing monoclonal antibodies (N-MAbs), which showed a variety of interserotypic reactivity patterns when examined in a neutralization test and an enzyme-linked immunosorbent assay against 15 HRV and 2 animal RV strains. Serological study with the six cross-reactive N-MAbs revealed antigenic variations in some HRV strains within the same serotype as well as a marked antigenic difference between serotype 2 strains and serotype 1, 3, and 4 strains. Epitope analysis of the antigenic variants resistant to the six individual cross-reactive N-MAbs suggested the existence of at least three distinct cross-reactive neutralization epitopes on VP3 of HRV.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2437322      PMCID： PMC254165     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  32 in total

1.  Epitope-specific antibody response to murine hepatitis virus-4 (strain JHM).

Authors:  P J Talbot; A A Salmi; R L Knobler; M J Buchmeier
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

2.  Production of subgroup-specific monoclonal antibodies against human rotaviruses and their application to an enzyme-linked immunosorbent assay for subgroup determination.

Authors:  K Taniguchi; T Urasawa; S Urasawa; T Yasuhara
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

3.  Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus.

Authors:  H B Greenberg; J Valdesuso; K van Wyke; K Midthun; M Walsh; V McAuliffe; R G Wyatt; A R Kalica; J Flores; Y Hoshino
Journal:  J Virol       Date:  1983-08       Impact factor: 5.103

Review 4.  Rotaviruses: a review.

Authors:  M K Estes; E L Palmer; J F Obijeski
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

5.  Protection studies in colostrum-deprived piglets of a bovine rotavirus vaccine candidate using human rotavirus strains for challenge.

Authors:  G Zissis; J P Lambert; P Marbehant; D Marissens; M Lobmann; P Charlier; A Delem; N Zygraich
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

6.  Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.

Authors:  T Vesikari; E Isolauri; E D'Hondt; A Delem; F E André; G Zissis
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

7.  Natural variation of poliovirus neutralization epitopes.

Authors:  R Crainic; P Couillin; B Blondel; N Cabau; A Boué; F Horodniceanu
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

8.  Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH.

Authors:  R G Webster; L E Brown; D C Jackson
Journal:  Virology       Date:  1983-04-30       Impact factor: 3.616

9.  Induction of cross-reactive serum neutralizing antibody to human rotavirus in calves after in utero administration of bovine rotavirus.

Authors:  R G Wyatt; A Z Kapikian; C A Mebus
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

10.  Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization.

Authors:  Y Hoshino; R G Wyatt; H B Greenberg; J Flores; A Z Kapikian
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226
View more
  58 in total

1.  Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope.

Authors:  D Y Chen; M K Estes; R F Ramig
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  SA-11 rotavirus binding to human serum lipoproteins.

Authors:  F Superti; L Seganti; M Marchetti; M L Marziano; N Orsi
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

3.  Development of cDNA probes for typing group A bovine rotaviruses on the basis of VP4 specificity.

Authors:  A V Parwani; B I Rosen; M A McCrae; L J Saif
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

4.  Isolation of human monoclonal antibodies that neutralize human rotavirus.

Authors:  Kyoko Higo-Moriguchi; Yasushi Akahori; Yoshitaka Iba; Yoshikazu Kurosawa; Koki Taniguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

5.  Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein.

Authors:  G Larralde; B G Li; A Z Kapikian; M Gorziglia
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

6.  Reverse genetics system for introduction of site-specific mutations into the double-stranded RNA genome of infectious rotavirus.

Authors:  Satoshi Komoto; Jun Sasaki; Koki Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

7.  Generation of recombinant rotavirus with an antigenic mosaic of cross-reactive neutralization epitopes on VP4.

Authors:  Satoshi Komoto; Masanori Kugita; Jun Sasaki; Koki Taniguchi
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

8.  Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure.

Authors:  Y J Zhou; J W Burns; Y Morita; T Tanaka; M K Estes
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Subgroup and serotype distributions of human, bovine, and porcine rotavirus in Thailand.

Authors:  Y Pongsuwanne; K Taniguchi; M Choonthanom; M Chiwakul; T Susansook; S Saguanwongse; C Jayavasu; S Urasawa
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

10.  Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.

Authors:  L Padilla-Noriega; R Werner-Eckert; E R Mackow; M Gorziglia; G Larralde; K Taniguchi; H B Greenberg
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.